Invent Ventures Analyst Report: Shows Revenue Growth with Successful Portfolio Companies by Small Cap Traders

NEW YORK, Oct. 20, 2014 /PRNewswire/ -- Analyst Report by Small Cap Traders. Invent Ventures IDEA, a technology venture firm, has generated impressive early results by leveraging its cumulative knowledge and experience. The firm had a 36% year-over-year growth in revenues for the full year of 2013 with total revenues from its portfolio of companies growing from $105,987 to $144,144.

One of its portfolio companies, Revenue.com, is ranked second in Content Marketing & Native Advertising market share by Leadledger.com. Another portfolio company Sanguine Biosciences, Inc. has signed an agreement with Mayo Clinic Bioservices, under which Mayo Clinic Bioservices will process, store and ship biospecimens gathered by Sanguine for the purpose of developing new therapies.

An analyst report which details the current situation, an overview of the company and analyst comments can be viewed in its entirety by using the link below. There is no cost obligation required to view this report:

http://bit.ly/-IDEA-AnalystReport

Copy and paste to browser may be required.

About Small Cap Traders

Once you have read our reports written by financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties.

3rd party financial analysts provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Forward-Looking Disclaimer   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   

Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the analyst report.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcaptraders.com. For any urgent concerns or inquiries please contact us at editor@smallcaptraders.com.

Contact: editor@smallcaptraders.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/invent-ventures-analyst-report-shows-revenue-growth-with-successful-portfolio-companies-by-small-cap-traders-815490749.html

SOURCE Small Cap Traders